675 Results
3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.

4

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.

6

Study: There might be 3 different types of ADHD

March 4, 2026

The University of Cincinnati's Melissa DelBello was featured in a National Geographic article discussing recent research she coauthored that used brain imaging to identify three distinct subtypes of of ADHD, each with its own chemical interactions in the brain.

7

UC studies supplement, therapy alternatives to treat depression

March 2, 2026

Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.

8

Fentanyl overdoses hitting the elderly

February 23, 2026

The University of Cincinnati's Daniel Arendt was featured in a Jacksonville news station News4Jax report on the increase in fentanyl overdose deaths in seniors.